Longeveron Inc.

Quick facts

Phase 2 pipeline

• Lomecel-B medicinal signaling cells
  Allogeneic mesenchymal stem cells that secrete bioactive factors to modulate immune responses and promote tissue repair.

Phase 1 pipeline

• Longeveron Mesenchymal Stem Cells

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Longeveron Inc. portfolio CI brief
• Longeveron Inc. pipeline updates RSS

Related

• Sector hub: All tracked pharma companies